severe neonatal hypotonia-seizures-encephalopathy syndrome due to 5q31.3 microdeletion

ORPHA: 314655

Overview

human disease

Available Treatments (0)

No treatments linked yet

Clinical trials or compassionate use may be available — consult a specialist.

Clinical Presentation

Signs and symptoms associated with severe neonatal hypotonia-seizures-encephalopathy syndrome due to 5q31.3 microdeletion, sourced from HPO and Orphanet clinical annotations.

High palateNarrow foreheadMicrognathiaTelecanthusPtosisDelayed speech and language developmentMotor delayNeonatal hypotoniaDeep philtrumRespiratory distressEEG abnormalityDepressed nasal bridgeSparse lateral eyebrowProminent metopic ridgeFeeding difficulties in infancyTented upper lip vermilionSevere intellectual disabilityBrain atrophyDelayed myelinationBrain imaging abnormalityLow-set earsAnteverted naresDownslanted palpebral fissuresSeizureMyoclonusAbnormal heart morphologyApneaHypoventilationShort noseRecurrent pneumoniaSevere muscular hypotoniaPolydactylyEpileptic spasmSpeech apraxiaFocal tonic seizureAspiration pneumoniaBilateral tonic-clonic seizure with generalized onset

Classification & Codes

Orphanet Code

ORPHA:314655
severe neonatal hypotonia-seizures-encephalopathy syndrome due to 5q31.3 microdeletion
OrphanetORPHA:314655
Treatments0 drug(s)
Symptoms on record37 signs
Statuspublished
Factual Authority
Last Updated3/20/2026
Clinical DataHPO · Orphanet
Drug DataFDA · EMA · CDSCO